BrightSpring Health Services, Inc. Common Stock (BTSG) is a Healthcare stock trading at $70.52 (as of 2026-07-20), with a market capitalization of $13.67B and a trailing P/E of 44.1. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
BrightSpring Health Services, Inc. operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations. It serves patients through clinical providers and pharmacists. BrightSpring Health Services, Inc. was formerly known as Phoenix Parent Holdings Inc. and changed its name to BrightSpring Health Services, Inc. in May 2021. The company was founded in 1974 and is based in Louisville, Kentucky.
BrightSpring Health Services provides home and community-based healthcare services in the United States, focused on pharmacy and provider services (clinical and supportive care delivered through pharmacists, clinical providers, and related home and community settings), and it earns money through revenue generated in its Pharmacy Solutions and Provider Services segments.
BrightSpring’s profit engine is driven mainly by its Pharmacy Solutions segment, which is the larger revenue contributor (about 3.2B of 3.6B) and also shows the larger operating earnings before interest, taxes, depreciation and amortization (0.12B versus 0.05B for Provider Services).
| Pharmacy Solutions | $3.2B |
| Provider Services | $0.4B |
Business quality (Mixed): The provided facts clearly separate Pharmacy Solutions and Provider Services by both revenue and operating earnings (EBITDA), and they include execution-oriented operating KPIs, but they do not show growth rates or customer level economics, so investors mainly have to watch segment operating earnings alongside service quality metrics.
Valuation: At 45× earnings, BTSG trades 80% above the Healthcare Services average (25×). Note: one-time items can distort reported P/E.
| Price | $70.52 |
| Market Cap | $13.67B |
| P/E Ratio | 44.1 |
| EV / EBITDA | 29.0 |
| Price / Book | 6.91 |
| Price / Sales | 1.00 |
| FCF Yield | 3.0% |
| DCF Value (model) | $21.70 |
| DCF Upside vs Price | -69.2% |
| Revenue (TTM) | $12.91B |
| Net Margin | 1.5% |
| Revenue Growth (YoY) | 25.6% |
| EPS Growth (YoY) | 386.7% |
| FCF Growth (YoY) | 20.8% |
| Altman Z-Score | 4.15 (safe) |
| Stock P/E | 44.1 |
| Sector P/E (Healthcare) | 21.1 |
| Industry P/E (Healthcare Services) | 28.9 |
| vs Sector | 109.5% |
| vs Industry | 52.7% |
| Top Institutional Holder | Kohlberg Kravis Roberts & Co. L.P. ($1.78B) |
| Institutional Holders Tracked | 10 |
| Sector | Healthcare |
| Industry | Healthcare Services |
| CEO | Jon Rousseau |
| Employees | 37,000 |
| Country | US |
| IPO Date | 2024-01-26 |
Data as of 2026-07-20.
Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.